10.5800.00% ( 0.000 )
Delay Opening Auction: Nov 16, 09:00:00Valuation
Current ValuationThe current P/E ratio is 15.02, within the reasonable range, cheaper than 75.06% of the time in the past 3 years, and the industry ranks 20/53, the industry Median 6.78.
15.02xP/E
HK$10.58Stock price
HK$0.70Earnings per share
15.02xP/E
Stock priceHK$10.58Earnings per shareHK$0.70
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 18.64x
- Typical range
- 7.81x–33.07x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 6.78x
010203040
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 6.78x
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
01093HKCSPC PHARMA | 10.82x | 128.56% | HK$92.53B |
02196HKFOSUN PHARMA | 10.68x | 10.29% | HK$43.74B |
02096HKSIMCERE PHARMA | 15.02x | 31.93% | HK$27.17B |
00867HKCMS | 13.89x | 41.06% | HK$24.53B |
01513HKLIVZON PHARMA | 12.24x | 17.45% | HK$22.20B |
00512HKGRANDPHARMA | 13.81x | 45.32% | HK$15.32B |
02005HKSSY GROUP | 14.58x | 24.61% | HK$7.40B |
03613HKTONGRENTANGCM | 12.69x | 15.96% | HK$4.57B |
01666HKTONG REN TANG | 10.63x | 21.20% | HK$3.75B |
00719HKSHANDONG XINHUA | 13.61x | -- | HK$3.63B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
